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ABSTRACT 
 
Objectives 
The widespread use of complementary therapies alongside biomedical treatment by 
people with cancer is not supported by evidence from clinical trials. We aimed to use 
combined qualitative and quantitative data to describe and measure individualized 
experiences and outcomes. 
Methods 
In three integrative Cancer Support Centres (two breast cancer only) in the UK, 
consecutive patients completed the individualised outcome questionnaire Measure 
Yourself Concerns and Wellbeing (MYCaW) before and after treatment. MYCaW 
collects quantitative data (7-point scales) and written qualitative data and the 
qualitative data were analysed using published categories. 
Results 
782 participants, 92% female, mean age 51yrs, nominated a wide range of concerns. 
Psychological and emotional concerns predominated. At follow-up, the mean change 
(improvement) in scores (n=588) were: concern 1, 2.06 (95% CI 1.92-2.20); concern 
2, 1.74 (95% CI 1.60-1.90); and wellbeing, 0.64 (95% CI 0.52-0.75. The most 
common responses to ‘what has been the most important aspect for you?’ were 
‘receiving complementary therapies on an individual or group basis’ (26.2%); 
‘support and understanding received from therapists’ (17.1%) and ‘time spent with 
other patients at the centres’ (16.1%). Positive (61.5%) and negative (38.5%) 
descriptions of ‘other things affecting your health’ correlated with larger and smaller 
improvement in concerns and wellbeing respectively 
Conclusions 
In a multi-centre evaluation the MYCaW questionnaire provides rich data about 
patient experience, changes over time and perceptions of what was important to each 
individual with cancer within that experience.  It is unlikely that meaningful 
evaluations of this complex intervention could be carried out by quantitative methods 
alone.  
 
 
Keywords: Cancer, complementary therapies, qualitative, outcome measures, patient 
reports, oncology. 
 
  
  
INTRODUCTION 
An increasing number of people with cancer are coming to see the use of 
complementary therapies as an adjunct to hospital cancer treatment rather than as an 
alternative approach [1-5]. In this supportive role, complementary therapies are 
widely used after a cancer diagnosis and in the UK they are included in National 
Health Service (NHS) guidelines ‘Improving Supportive and Palliative Care for 
Adults with Cancer’[6]. These therapies may be accessed from individual 
practitioners, usually in the private sector, or from cancer support centers. The term 
‘integrative’ is used to describe health care services that combine biomedical and 
complementary therapies. In the UK these centres are in hospital or community 
settings and may be funded by the National Health Service (NHS) and/or by 
charitable bodies. They aim to provide patient-centered care and physical, emotional, 
psychological and spiritual support. 
 
Although complementary therapies are commonly used by people with cancer[7-9], 
randomized controlled trials of specific therapies in this population rarely demonstrate 
any benefit in terms of quality of life. Our experience of working in cancer support 
services leads us to suggest that this is because, for this population especially, the 
benefits of specific therapies are intertwined with the benefits of the therapeutic 
relationship and other contextual factors. Cancer support centres not only focus on 
providing complementary therapies to address the specific problems faced by people 
with cancer, such as side effects from treatment, but are also concerned with the 
environment and the manner in which the service is delivered. Consequently it has 
been suggested that cancer support care may best be evaluated using whole systems 
methods of research which combine quantitative and qualitative methods, focus on 
patient-centred outcomes, and acknowledge the necessity of iterative cycles of 
research[10]. This research strategy is similar to that promoted by the Medical 
Research Council (MRC) in its ‘Framework for design and evaluation of complex 
interventions to improve health’, which also acknowledges the importance of  
exploratory combined qualitative and quantitative data descriptive studies in order to 
understand the different components of complex interventions and the 
interconnections between them[11;12]. Although the MRC framework retains the 
‘definitive randomized controlled trial (RCT)’ as its goal, it is acknowledged that 
there are some situations where RCTs may prove to be inappropriate, impossible, or 
inadequate and may need to be supplemented by observational studies [13]. It appears 
that cancer support care may be one of those situations. Whatever the research design 
chosen, appropriate outcome tools and methods are a vital resource for researchers in 
this field. 
 
Methods for combining quantitative and qualitative methods in the context of large 
scale experimental or observational research designs are developing rapidly[14]. Such 
designs have only rarely, however, been applied to investigating cancer support care, 
an intervention which is both highly individualized and also difficult to control 
experimentally because of ethical issues [15,16]. This paper reports on the use of an 
outcome tool, the Measure Yourself Concerns and Wellbeing (MYCaW) 
questionnaire, which has been developed by a team of researchers, service providers 
and service users, specifically as a combined qualitative and quantitative data 
approach in this population. MYCaW is an individualized questionnaire which allows 
the respondent to specify their concerns, score the severity of these concerns and their 
level of wellbeing, and also write about important aspects of their lives and their 
  
treatment experiences in their own words[17].Repeated completion provides 
quantitative and qualitative data that can be compared at different stages of treatment.  
MYCaW is now being used in at least 10 UK cancer support centres and a few centres 
in North America and is reported to be popular because of its brevity, acceptability, 
appropriateness, and responsiveness to change[17;18] Details of the development of 
MYCaW, as an adaptation of Measure Yourself Medical Outcomes Profile, MYMOP, 
and the psychometric properties of these measures are reported elsewhere [17,20 21] 
Summarising and analyzing the written qualitative data collected with MYCaW can 
prove challenging, but recent work by Polley et al (2007), using the same qualitative 
data reported in this paper, has provided a structure for such analysis, thus promoting 
more detailed and comparative reporting of the qualitative data alongside the 
quantitative scores[19].  
 
This paper reports the findings of service evaluations, carried out in three integrative 
cancer support centres in England, that utilized MYCAW to investigate the  
experiences of people with cancer and perceived changes in their concerns/problems 
and wellbeing over time.   
 
 
METHOD 
 
Settings and study population. 
Data collection took place in three cancer support centres in England between 2004-
2006. The data were collected as part of ongoing internal audit procedures, not as part 
of a research study and was not therefore subject to research ethics approval. All data 
were anonymised on-site before being shared and analysed for the purpose of this 
paper. Two of these centres were day centres run by Breast Cancer Haven (BCH) in 
London and Hereford. BCH works with the NHS and other healthcare professionals to 
promote and provide responsible and effective integrated breast cancer care. They 
offer support, information and complementary therapies to anyone affected by breast 
cancer. Their Haven Programme provides up to 12 hours of complementary therapies 
free of charge and is designed to help patients feel better and develop a healthier 
lifestyle. The third centre, Penny Brohn Cancer Care (PBCC, formally Bristol Cancer 
Help Centre) also promotes the integration of complementary and orthodox medical 
treatment, and runs 3 and 5 day residential courses, as well as a drop in service for the 
local population.  It aims to provide physical, emotional and spiritual support through 
the use of complementary therapies and self-help techniques. All people with cancer 
are offered complementary therapies, irrespective of their cancer stage or prognosis or 
the type or stage of hospital medical treatment they are receiving. A more detailed 
description of the settings and methods of this study are published elsewhere[19].  
 
The MYCAW questionnaire and its administration 
The MYCAW questionnaire is completed with structured guidance on the first 
occasion and can be self-completed thereafter. It requires people with cancer to 
choose and write down in their own words ‘one or two concerns or problems which 
you would most like us to help you with’ and to score the severity of these concerns 
‘now’ on a seven point scale - between 0 (not bothering me at all) to 6 (bothers me 
greatly). They also score their ‘general feeling of wellbeing’ on the same scale. On the 
follow-up questionnaire the respondent re-scores the original concerns and their 
wellbeing without seeing their original scores. In addition, there are two open 
  
questions ‘other things affecting your health’ and ‘what has been most important for 
you?’ (see www.pms.ac.uk/mymop for full questionnaire). 
All people with cancer attending the centres during the study period were 
given a MYCaW form to fill in.  At BCH, the initial MYCaW form was administered 
at the start of their complementary therapy programme (of up to 12 hours therapies 
pus groups and classes), and the follow-up form was posted out after 10 hours of 
therapies or if the patient had not returned for 3 months.  At PBCC, all people with 
cancer received the initial MYCaW form in the post before arriving for their 5 day 
residential course and completed it at their initial assessment, and the follow-up form 
was posted 4 weeks after the course.   
 
 
Data Analysis 
A merged dataset was constructed using anonymised data from all three centres, 
including both the quantitative MYCaW scores and the exact wording for each 
concern and the written answers to the open questions (qualitative data). Descriptive 
statistical analysis examined the distribution of gender, age and cancer site in the 
sample population (n=782). In view of the possibility that the score data can be 
argued to be on an ordinal rather than interval scale non-parametric tests were used 
throughout the analysis. 
Qualitative data were first categorised via the process of a content analysis and 
a framework of categories was produced [19]; this current paper therefore represents 
the results of the proportions of responses in different categories and supercategories.  
All people with cancer were guided to state ‘one or two’ concerns, although some 
people still stated more than two; the majority of these extra concerns, however, fell 
within the same supercategory.  
The ‘before and after’ scores for concern 1, concern 2 and wellbeing were 
analysed using Wilcoxon signed rank tests applying a cut-off value for statistical 
significance of p=0.05 (two-sided). Respondents were only included in this analysis if 
they had scored both concern 1 and wellbeing on both the first form and the follow up 
form (the second concern is optional).  In addition, ‘change scores’ were calculated 
for each concern and wellbeing by subtracting the ‘before’ score from the ‘after’ 
score.  With the BCH data, correlative analyses were carried out between these 
change scores and the number of hours of complementary therapies received or the 
duration of the therapy package using Spearman’s rank order tests.   
For the open questions ‘other things affecting your health’ and ‘What has been 
most important for you?’, many respondents wrote multiple points which were all 
coded and the proportion of responses in each category was calculated.  For ‘other 
things’ each point was categorized as a ‘positive’ or ‘negative’ effect and each 
respondent was assigned to one of four categories of ‘other things’ (responses 
containing ‘only positive’ ‘only negative’, ‘positive and negative’ and ‘nothing 
mentioned’). 
The Kruskal-Wallis test was used to establish whether the concern or 
wellbeing ‘change scores’ were significantly associated with ‘other things’ happening 
in the lives of people with cancer, using the four categories described above.  A series 
of Mann-Witney tests between each pair of the four sub-categories was conducted to 
confirm the differences in the change scores between sub-categories. 
 
 
RESULTS 
  
Response rates 
Baseline MYCaW data were collected from 782 people with cancer between 
September 2004–January 2006 at BCH (London n=268, Hereford n=153) and 
between January 2004-December 2005 at PBCC (n=361).  The overall response rate 
for the follow-up MYCaW form was 78% (n=607) comprising of 62% at BCH (n= 
260) and 96% at PBCC (n=347).  A further 19 people were not included in the 
quantitative analysis  as scores on the follow-up MYCaW forms were either missing 
or filled out incorrectly (BCH n=5, PBCC n=14), thus 588 people with cancer both 
responded to the MYCaW follow-up form and scored concern 1 and wellbeing 
correctly on both MYCaW forms (BCH n=255, PBCC n=333).  Participants who did 
not return to BCH for therapies were sent a questionnaire to find out why and cited 
reasons such as: too far to travel, and they had to return to work so did not have time. 
Reasons for lack of returned posted forms at BCH included, lost in the post 
(approximately 5%), bereavement, too busy to fill it in, or changed address without 
informing the Havens.   
 
Characteristics of participants and length of treatment 
Overall the gender distribution was 91.7% female (BCH 100% and PBCC 77%) and 
the mean age was 51.43 (range 19-90 years). Cancer site for the combined data set 
was 79.2% breast (BCH 100% and PBCC 41.3%); 3.8% colon; 2.9% lung; 1.4% 
prostate; 17.4% ‘others’ and 1.5% unknown. At BCH the mean hours of therapy were 
5.7 (range 1-16 hours) but because care is delivered to fit around medical treatment 
the overall period of care varied widely and the mean time between filling out the 2 
forms was 6.5 +/- 3.4 months. At PBCC all people with cancer received a 5 day 
residential course and the mean time between filling out the first and follow-up 
MYCaW forms was 7 weeks +/-3.2 weeks.   
 
Concerns and problems and wellbeing 
The 782 respondents who completed an initial MYCaW form reported a total of 1729 
concerns, as some recorded more than the two concerns they were asked for.  Data 
were analysed using a published framework [19] and responses allocated to one of 
four possible supercategories (Figure 1).  
 
Table 1 shows the MYCaW scores, before and after the treatment programme 
(described above), for all people who completed a follow-up questionnaire.  All mean 
changes in scores were highly significant (p<0.0005). Concern 1 (n=588) showed a 
mean change in scores of 2.06 (95% CI 1.92-2.20), concern 2 (n=533) a mean change 
of 1.74 (95% CI 1.60-1.90), and wellbeing (n=588) a mean change of 0.64 (95% CI 
0.52-0.75). There was very little difference in change scores between the cancer 
centres, despite there being some differences in the types of concerns and cancer types 
described. The distribution of wellbeing scores showed a positive change for 53.7 % 
of patients, no change for 26.2% and a negative change for 20.1% of patients (Figure 
2). 
  
For the BCH data, no significant correlations existed between hours of therapies 
received as part of the treatment programme and change scores (Spearman’s rank 
order test, r= 0.026, 0.068 and -0.027 for concern 1, concern 2 and wellbeing 
respectively), or between the duration of the complementary therapy package and the 
score changes (Spearman’s rank order test r= 0.019, -0.019 and 0.069 for concern 1, 
concern 2 and wellbeing respectively). 
  
 
What has been most important for you? 
Out of the 588 participants, 508 responded to the open optional question, ‘Reflecting 
on your time with [the centre], what were the most important aspects for you?’ 981 
items were reported, which were assigned to the ten published analytic categories, as 
shown in Figure 3. Negative feedback was only received from 2% of respondents and 
no noticeable difference in reporting frequency occurred between BCH and PBCC. 
 
Other things affecting your health? 
The follow up MYCaW questionnaire has an open question ‘Other things affecting 
your health’ with the subtitle of  ‘The treatment that you have received here may not 
be the only thing affecting your concern or problem. If there is anything else which 
you think is important, such as changes which you have made yourself, or other things 
happening in your life, please write it here.’  The analytic framework for this written 
qualitative data consists of 17 categories within 6 supercategories[19].  Out of the 588 
participants, 364 responded to the question and reported 498 items, that were assigned 
to 6 supercategories, (Figure 4).  Each supercategory comprised of 2-4 categories, and 
the reporting frequencies were extremely similar between BCH and PBCC. Overall 
the most frequently reported category was ‘negative health issues related to cancer’.  
The top category in each supercategory is detailed in the figure, and is the same for 
each centre unless stated otherwise. 
Each participant was classified as either ‘non-respondent’ (n=224), ‘positive 
only’ (n=173), ‘negative only’ (n=149) or ‘positive and negative’ (n=42). Overall 
61.5% of the categorised items were classified as positive and 38.5% as negative.  
Where responses were ‘positive only’, this was associated which greater 
improvements in concern 1, concern 2 and wellbeing compared with the non-
responders. In turn, the non-responders had more improvement than the ‘negative 
only’ responses. These differences were all statistically significant (Kruskal Wallis 
test p<0.0005). This ranking was most pronounced with the wellbeing scores when 
compared to the concerns scores.  The difference between positive responders and 
non-responders, and between negative responders and non-responders was confirmed 
by the Mann-Whitney U test on change scores for wellbeing (p<0.0005 in both cases). 
 
 
DISCUSSION 
This multi-centre observational study has demonstrated the complexity of cancer 
support care as experienced by people with cancer and the ability of the MYCaW 
questionnaire to encompass and measure important facets of this experience. Using 
this individualised questionnaire, people with cancer nominated a wide range of 
concerns and problems as initial reasons for seeking help, amongst which 
psychological and emotional concerns predominated. Following treatment they not 
only rescored the ‘bothersomeness’ of these concerns but also added information 
about what had been the most important aspects of their care at the centre and what 
else had been happening in their life that may have affected their progress. We have 
illustrated how this combination of quantitative and qualitative data from 588 people 
with cancer in three centres can be analysed and presented in a concise and accessible 
manner. 
Achieving high response rates in this population, many of whom were in a time of 
crisis and concomitant biomedical treatment is a difficult challenge, especially in a 
‘real-life’ observational study that was carried out with few extra resources. The fact 
  
that all eligible participants completed the initial form and 78% of these completed a 
postal follow-up confirms that MYCaW is both feasible and acceptable in this 
context. Following their treatment programmes, the initial highly bothersome 
concerns and problems improved by a mean of 2.06 (95% CI 1.92-2.20) for concern 
1, and 1.74 (95% CI 1.60-1.90) for concern 2. Previous work with similar 7 point 
scales indicates that a change of over 0.7 – 1.0 is likely to be clinically significant and 
that the mean changes reported here are likely to be highly significant to the clients 
concerned[20-23]. The smaller change in wellbeing scores (mean change of 0.64, 
95% CI 0.52-0.75), is to be expected when focused interventions are provided in the 
context of major distress or disability. In these situations complementary therapies 
may aim to prevent a deterioration in quality of life, rather than a positive 
improvement[24]. This small change in wellbeing also indicates that clients are 
scoring their own perceptions and are not misrepresenting their experiences through a 
desire to please. The nature of the concerns and the degree of change in concern and 
wellbeing scores are similar to those reported in other studies that have used MYCaW 
in cancer support centres[17;25] and in people with cancer consulting spiritual 
healers[18].  
 
In this observational study design, it is not possible to prove cause and effect in a 
statistical manner but the qualitative data indicates that participants considered many 
aspects of the care to be important. Over a quarter of clients perceived the specific 
therapy as the most important feature and clients also valued feeling supported and 
cared for by staff and other clients and appreciated the other facilities offered.   
 
The lack of correlation between the hours or duration of therapy at BCH and the 
degree of improvement in the concern score may be due to the individualised nature 
of the treatment offered. The therapy packages for people with cancer are tailored to 
the unique needs of each individual, taking into account their diagnosis, prognosis, 
MYCaW concerns, wellbeing and biomedical treatment schedule, and are reviewed as 
the programme progresses. Hence, while some may improve with a couple of hours of 
therapy or over a short time period, others make much slower progress. Concerns that 
are psychological and emotional are often complex in nature and may require many 
hours of counselling, life coaching or mind-body therapy. They may also require time 
between treatments for the patient to process the situation and make life changes.  
 
Analysing and combining the quantitative and qualitative data collected by MYCaW 
illustrates how the contextual factors that were gathered using qualitative methods 
interacted with the quantitative outcomes of the main concerns. It is of some 
importance that there was such a strong association between positive and negative 
‘other things’ happening in patients’ lives and the score changes they recorded.  Those 
that reported a positive event improved more for both concerns and wellbeing than the 
non-responders, and the non-responders had more improvement than those reporting a 
negative event. Whilst this result may seem, from a lay perspective, self-evident, it 
demonstrates complex interactions that are important at the level of service provision 
which are often not taken into account in experimental research designs. 
 
In this paper, we have reduced written qualitative data to categorical data which can 
then be analysed quantitatively. Being able to feed this qualitative data into an 
overarching analysis has the advantage of making such an analysis richer and more 
grounded in the whole experience of the person with cancer. However, it also results 
  
in a loss of detail and language of the cancer patients’ voices, because the primary 
qualitative data are not available to the reader. The qualitative data collected in this 
study is presented in more detail elsewhere [19] and we recommend that, at a 
minimum, reports of MYCaW data present some direct quotes that are assigned to 
each of the main categories. In addition, this written data, although often brief, is rich 
in meaning and significance, and is suitable for more in depth and conceptual analyses 
if resources are available.  The written answers to the question ‘what has been most 
important to you?’ describe aspects of the experience of attending for care which were 
somewhat different to the initial focused concerns or problems. The responses 
demonstrate that both the therapy and the contextual factors are important to people 
with cancer and are vital for understanding the complex totality of good service 
provision in cancer care. The value placed on feeling supported and understood and 
on relationships with therapists, staff and other people with cancer have also been 
found in more in-depth qualitative studies of similar populations [4;26-29].  
 
One of the limitations of the study, in terms of generalisability, is the over-
representation of women with breast cancer in the sample. The type of concerns and 
the degree of benefit, however, was similar in both BCH centres and the PBCC where 
people have a range of cancer types. It is also of interest to note that the importance of 
psychological and emotional concerns found in this study has also been found in 
studies where male cancer patients have been well represented and that 
complementary therapies had a potentially important role to play in the helping male 
cancer patients communicate their need for comfort, emotional and psychological 
support [28]. Our evaluation is also limited by a relatively short period of follow-up 
observation: a common situation when resources are limited. Further work using 
MYCaW over extended periods of time would be useful, especially in view of the 
sequential phases of decision making and use of complementary therapies described 
by Truant & Bottorff (1999). Their study of women with breast cancer suggests that 
interconnected phases include ‘getting something in place’, ‘getting a personalised 
regime in place’ and ‘fine-tuning a regimen to live with’ [30]. A longer term study 
could utilise a rolling series of MYCaW questionnaires to demonstrate changes in 
concerns and valued effects over time.  Such studies may also throw more light onto 
the changes found by in-depth qualitative work, such as ‘transformation’ [26] and 
‘unstuckness’ [31] which have not been elucidated in our work to date. 
 
CONCLUSIONS 
This study demonstrates that complementary therapies for cancer support can be a 
valuable adjunct for people with cancer, thus validating the inclusion of such therapy 
in clinical guidelines and care pathways. Almost half of the participants nominated 
psychological and emotional concerns, and others requested help with general 
wellbeing, physical problems and the side effects of orthodox treatments.  Concerns 
were severe at the start of treatment and showed a clinically significant improvement 
at the end of treatment of 2.06 (for concern 1) and 1.74 (for concern 2) points on a 
seven point scale. Participants valued the specific therapy received and the support, 
understanding and positive relationships with both staff and other people with cancer.  
Their response to their complementary treatment was affected by many other aspects 
of their lives, both positive and negative. The use of the MYCaW questionnaire in a 
multi-centre observational design has provided rich and complex data about the 
patient experience and the changes over time, including perceptions of what was 
important to each individual within that experience. It is unlikely that a meaningful 
  
evaluation of such a complex intervention could be carried out by quantitative 
methods alone. The combined qualitative and quantitative data approach employed in 
this study could be used, with or without more in-depth qualitative methods and/or 
methods of economic evaluation, to build an increasingly robust and generalisable 
understanding of the role of complementary therapies and cancer support care.  In 
addition, using MYCaW could be an invaluable component in the internal service 
evaluation for any cancer support service. 
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Before 
Treatment 
After 
Treatment Change in Score MYCaW scores 
Mean (SD) Mean (SD) Mean (95%CI) 
Concern 1 (n = 588) 
BCH (n = 255 ) 
PBCC (n = 333) 
4.79 (1.20) 
4.92 (1.09) 
4.68 (1.26) 
2.73 (1.62) 
3.02 (1.68) 
2.51 (1.54) 
2.06* (1.92-2.20) 
 
 
Concern 2 (n = 533) 
BCH (n = 228) 
PBCC (n = 305) 
4.45 (1.24) 
4.53 (1.18) 
4.42 (1.25) 
2.70 (1.58) 
2.86 (1.69) 
2.61 (1.47) 
1.74* (1.60-1.90) 
Wellbeing (n = 588) 
BCH (n = 255) 
PBCC (n = 333) 
2.91 (1.32) 
3.09 (1.26) 
2.79 (1.33) 
2.27 (1.32) 
2.49 (1.38) 
2.11 (1.24) 
0.64* (0.52-0.75) 
 
 
Table 1.  MYCaW scores, 0 (as good as it can be) to 6 (as bad as it can be). 
*significant at p<0.0005. 
 
  
Figure 1:  Types of Concerns reported by patients.  
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BCH: ‘mind-body’  
PBCC: ‘information received’ 
Types of Concerns and Problems: 782 patients reported 1729 concerns, which were analysed using a 
published framework[17].  The three most reported categories for each supercategory are detailed above  
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Figure 2. Distribution of score changes for concern 1, concern 2 and wellbeing.  
(A positive score change denotes an improvement)  
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Figure 3. Reflecting on your time at the centre what were the most important 
aspects for you?   
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Figure 4:  Other Things Affecting Health.  
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